Skip to main content
. 2020 Apr 30;49:25. doi: 10.1186/s40463-020-00420-x

Table 1.

Surveillance options for IP malignant transformation

Clinical investigation options Endoscopy
Computed Tomography
Magnetic Resonance Imaging
PET-CT with FDG
Biologic markers Genetic factors (P53, P21, MSX2, PDCD4, KRAS, PTEN)
Proteins (SCCa, fascin, surviving, COX-2, cell adhesion molecules, Ki-67 etc)
Viral (HPV, EBV)